Dai H Chung
Overview
Explore the profile of Dai H Chung including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
123
Citations
1846
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Cochran E, Jacobson J, Machchhar A, Qiao J, Chung D
Children (Basel)
. 2025 Feb;
12(2).
PMID: 40003262
Perioperative blood transfusion has been identified as a risk factor for postoperative infectious complications in adult patients with cancer. This study aimed to determine whether this association also exists in...
2.
Cochran E, Machchhar A, Qiao J, Chung D
J Am Coll Surg
. 2025 Jan;
PMID: 39868687
Introduction: Pediatric firearm-related injuries are now the leading cause of death among children in the United States. We sought to characterize the experience of a large free-standing children's hospital treating...
3.
Espinoza A, Shetty P, Jacobson J, Todd H, Harrell K, Trappey A, et al.
Cancer Med
. 2024 Sep;
13(17):e70207.
PMID: 39279240
Introduction: Synovial sarcoma is one of the most common soft tissue sarcomas in children. Guidelines regarding the adequate extent of resection margins and the role of re-resection are lacking. We...
4.
Jacobson J, Qiao J, Cochran E, McCreery S, Chung D
Front Oncol
. 2024 Jun;
14:1336031.
PMID: 38884093
Neuroblastoma accounts for approximately 15% of pediatric cancer-related deaths despite intensive multimodal therapy. This is due, in part, to high rates of metastatic disease at diagnosis and disease relapse. A...
5.
Cochran E, Jacobson J, Nehrubabu M, Qiao J, McCreery S, Chung D
J Am Coll Surg
. 2024 Jan;
238(4):463-478.
PMID: 38258890
Background: Socioeconomic factors have a significant impact on healthcare outcomes. Metrics such as area deprivation index (ADI) are used to quantify the anticipated influence of these factors. Here, we sought...
6.
7.
Bumpous L, Moe K, Wang J, Carver L, Williams A, Romer A, et al.
Oncogenesis
. 2023 Jun;
12(1):32.
PMID: 37336886
Collectively, the MYC family of oncoprotein transcription factors is overexpressed in more than half of all malignancies. The ability of MYC proteins to access chromatin is fundamental to their role...
8.
Jacobson J, Clark R, Chung D
Children (Basel)
. 2023 Feb;
10(2).
PMID: 36832517
High-risk neuroblastoma requires multimodal treatment including systemic chemotherapy, surgical resection, radiation therapy, stem cell transplant, and immunotherapy. Surgeons play a vital role in obtaining local control of neuroblastoma and must...
9.
Ryan M, Mutore K, DeLeon J, Gillory L, Chung D, Pandya S
J Am Coll Surg
. 2023 Feb;
236(4):630-635.
PMID: 36728227
Background: Despite minimal coding and billing training, surgeons are frequently tasked with both in clinical practice. This often results in denials for reimbursement based on incorrect or insufficient documentation, and...
10.
Qiao J, Liu J, Jacobson J, Clark R, Lee S, Liu L, et al.
PLoS One
. 2022 Dec;
17(12):e0277956.
PMID: 36525420
Standard treatment for patients with high-risk neuroblastoma remains multimodal therapy including chemoradiation, surgical resection, and autologous stem cell rescue. Immunotherapy has demonstrated success in treating many types of cancers; however,...